06/30/2026 09:18
Programmed Unifies Vendor Data and Streamlines Compliance Management With Boomi

Boomi, the data activation company for AI, today announced Programmed has transformed its vendor data management using the Boomi Enterprise Platform, establishing a single source of truth across compliance and operations, reducing manual effort, and providing real-time visibility across the vendor lifecycle. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260630814927/en/Programmed Unifies Vendor Data and Streamlines Compliance Manag...

06/30/2026 10:00
BeOne Medicines Announces Positive Phase 3 Results for BRUKINSA in Frontline Mantle Cell Lymphoma

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced positive topline results from the Phase 3 MANGROVE study (BGB-3111-306; NCT04002297) evaluating foundational BTK inhibitor BRUKINSA® (zanubrutinib) plus rituximab versus bendamustine plus rituximab (BR) in adult patients with previously untreated mantle cell lymphoma (MCL). MANGROVE is the first Phase 3, global, randomized trial to evaluate a BTK inhibitor-based chemotherapy-free regimen aga...

05/12/2026 12:41
Hytera Advances AI-Powered Critical Communications at Global Partner Summit 2026

Hytera Communications, a leading global provider of critical communications technologies and solutions, successfully concluded its annual Global Partner Summit (HGPS) 2026 on May 8 in Shanghai. Held under the theme “Advancing Together,” the summit brought together more than 500 attendees from over 60 countries to strengthen collaboration, share strategic insights, and explore future opportunities in AI-powered critical communications. This press release features multimedia. View the full relea...

06/30/2026 10:03
Klick Health Acquires Oxford PharmaGenesis, Bringing Together Unsurpassed Scientific-to-Commercial Capabilities for Life Sciences Clients

Focused on taking life sciences companies into the future, Klick Health today announced its acquisition of Oxford PharmaGenesis, the market-leading HealthScience communications consultancy renowned for its scientific and medical expertise, as well as value and market access consulting throughout Europe, Asia-Pacific, and North America. Today’s news brings together two of the leading independent agencies in life sciences. With Oxford PharmaGenesis’ expertise across medical affairs and market a...